logo logo
  • SV
  • |
  • EN
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & policies
  • Careers
  • News & events
    • Inify Laboratories news
    • Events
    • Newsletter
    • Publications & Presentations
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify Laboratories
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Support
    • Investor relations & media
logo logo
  • Start
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • About us
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & Policies
  • Newsroom
    • News
    • Events
    • Newsletter
    • Publications & Presentations
  • Careers
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Visit us
    • Support
    • Investor relations & media
  • SV
  • |
  • EN

Inify Laboratories: Solid topline growth, strong UK development, and positive response to gastrointestinal diagnostics

Financial reports, Investor News 2026-02-25
STOCKHOLM – February 25, 2026 – Inify Laboratories, a unique laboratory service that provides diagnostics within pathology, reports continued sales growth in the fourth quarter of 2025. Significant progress has […]
Read More

Correction: Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2026-01-30
Stockholm, Sweden, 30 January 2026, Reference is made to the stock exchange announcement made by Inify Laboratories AB (publ.) (the “Company“) on 27 January 2026 regarding allocation of new shares […]
Read More

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2026-01-27
Stockholm, Sweden, 27 January 2026; Inify Laboratories AB (publ.) (the “Company“) announces that the below primary insiders were allocated new shares at the subscription price in the repair issue announced […]
Read More

Inify Laboratories – Final Results of the Repair Issue

Investor News 2026-01-27
STOCKHOLM – 27 January 2026 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 12 January 2026 regarding the commencement of the […]
Read More

Inify Laboratories – Commencement of subscription period for Repair Issue

Investor News 2026-01-12
STOCKHOLM – 12 January 2026 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 19 December 2025 regarding the final results of […]
Read More

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2025-12-19
Stockholm – 19 December 2025 – Inify Laboratories AB (publ) (the "Company") announces that the below primary insider was allocated new shares at the subscription price in the private placement […]
Read More

Inify Laboratories announces final results of fully guaranteed private placement

Investor News 2025-12-19
STOCKHOLM – 19 December 2025 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (publ) (the "Company") on 9 December 2025 regarding the fully guaranteed […]
Read More

Inify Laboratories: Key information regarding Repair Issue

Investor News 2025-12-17
Reference is made to the stock exchange announcement published today, 17 December 2025, regarding the preliminary results of the private placement of new shares (the "Private Placement") in Inify Laboratories […]
Read More

Inify Laboratories announces preliminary results of fully guaranteed private placement

Investor News 2025-12-17
STOCKHOLM – 17 December 2025 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 9 December 2025 regarding the fully guaranteed private […]
Read More

Inify Laboratories – notification of trade

Investor News, Primary Insider Transactions 2025-12-16
Stockholm, Sweden, December 16, 2025; Inify Laboratories AB (publ.) has been notified that the following transactions have been completed by a primary insider in Inify; Fredrik Palm, CEO and primary […]
Read More
  • 1
  • 2
  • 3
  • …
  • 9
  • Our services

    Inify laboratory services

    For urology

    For gastroenterology

    For pathology

    For our customers

    Request a presentation

    Customer cases

    Information & policies

  • Inify Laboratories

    News

    Events

    Newsletter

    Publications & presentations

    Career

  • For Investors

    Invest in Inify Laboratories

    Investor news

    Financial reports (ENG)

    Financial reports (SWE)

    Financial calender

    Sustainability

    The share

    Executive team

    Subscription

     

     

  • Contact us

    +46 (0)8 26 73 30

    Support

    Find Inify Laboratories

  • Social media

    LinkedIn

    YouTube

    X

© Inify® Laboratories